Epilepsy, a chronic neurological disorder characterized by recurrent, unprovoked seizures, has seen significant advancements in its management over recent years. This article aims to provide a comprehensive update on these recent developments.
Several new AEDs have been introduced in the last decade. These drugs, including Brivaracetam, Perampanel, and Stiripentol, offer improved seizure control, better tolerability, and fewer drug interactions. They have broadened the therapeutic options for clinicians, particularly for refractory epilepsy.
There has been a significant evolution in epilepsy surgery. Minimally invasive techniques, such as laser interstitial thermal therapy (LITT) and stereotactic EEG-guided resection, have demonstrated efficacy in reducing seizure frequency and severity. These techniques offer a safer and more tolerable alternative to traditional resective surgery.
Neuromodulation therapies, including vagus nerve stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS), have emerged as promising treatment options for drug-resistant epilepsy. These therapies modulate neuronal activity, reducing seizure frequency and improving quality of life.
Advancements in genetic testing have led to the identification of numerous epilepsy-associated genes, facilitating precision medicine. Tailoring treatment based on a patient's genetic profile can optimize efficacy and minimize adverse effects, offering a personalized approach to epilepsy management.
In conclusion, the field of epilepsy management has seen significant advancements, with new AEDs, improved surgical techniques, neuromodulation therapies, and the advent of precision medicine. These developments have expanded treatment options, improved patient outcomes, and provided a more personalized approach to care. It is essential for healthcare professionals to keep abreast of these advancements to provide optimal care to their patients.
1.
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer
2.
Black Canadians Face Multiple Barriers to Blood Donation
3.
Stop Calling It Cancer; The Alcohol Paradox; Rural Patients Lose Ground in Screening
4.
Experts say oncology, primary care coordination necessary for best cancer patient outcomes
5.
Neural networks and label-free microscopy enable accurate detection of pancreatic tumors
1.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
2.
Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations
3.
Clinical Frameworks in Hematology for Better Care
4.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
5.
The Benefits of Understanding Haptoglobin High: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation